Envoy Medical, Inc.
COCH
$1.27
-$0.149-10.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 42.31% | 65.34% | 16.04% | -87.83% | -- |
| Total Depreciation and Amortization | 55.86% | 47.12% | 57.30% | 77.33% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.71% | -118.63% | -68.25% | 83.27% | -- |
| Change in Net Operating Assets | -203.52% | -408.70% | -520.65% | -575.00% | -- |
| Cash from Operations | -203.53% | -79.49% | -108.24% | -100.50% | -- |
| Capital Expenditure | -787.28% | -135.29% | 18.80% | 29.82% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -787.28% | -425.13% | 18.80% | 29.82% | -- |
| Total Debt Issued | 25.00% | -12.50% | 10.00% | 25.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 12,656.52% | 12,656.52% | 12,656.52% | -- |
| Cash from Financing | -41.81% | 98.71% | 143.04% | 169.96% | -- |
| Foreign Exchange rate Adjustments | 28.57% | 28.57% | 37.50% | 57.14% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.50% | 42,050.00% | 76,720.00% | 530.17% | -- |
